Abstract:Highlights • Preparing pharmaceutical salts of tetrahydropalmatine-sulfamic acid (THP-SA). • Improving solubility of THP by forming THP-SA introducing sulfamic acid. • THP and SA form pharmaceutical salts with the superhelical structure. • The improved solubility of THP may be due to the supramolecular helical structure. In order to improve the solubility of tetrahydropalmatine (THP), based on the summary of the relationship between cocrystal/salt synthesis and conformation of the protoberberine type compounds, we hypothesized that by introducing sulfamic acid (SA) with the sulfonic acid group may form cocrystal with THP and improve the solubility of THP. An unreported pharmaceutical salt (C 21 H 26 NO 4 ·SO 3 NH 2 , THP-SA) with supramolecular helical structure of THP and SA was designed and synthesized, and its structural characterization and properties were investigated. Structural analysis showed that the pharmaceutical salt with supramolecular helical structure were formed by introducing SA with THP. In THP-SA pharmaceutical salts, the protons of hydroxyl groups on the introduced SA were transferred to the nitrogen atom of the THP via charge-assisted hydrogen bonding (+) CAHBs (N + -H···O − ) to form a stable crystal structure. Meanwhile, the S atom in the sulfamic acid forms an angle of 116.16° with the O atom, so that the two THP and the two SA are connected sequentially by the 116.16° angle formed between the S atom and the O atom under the action of C–H⋯O hydrogen bond to form the R 3 4 (17) supramolecular synthons. And THP and SA are alternately connected by C–H⋯O hydrogen bonds, forming a left-handed helical chain and a right-handed helical chain along the a-axis, and the left-handed helical chains and right-handed helical chains are connected by C–H⋯O hydrogen bonds formed between the O atoms in SA and the C atoms in THP to form a 3D supramolecular double helix structure. As expected, solubility studies showed that the solubility of THP-SA was significantly improved compared to that of THP. The reason may be that the introduction of SA makes THP and SA form a helical steric structure, and the intermolecular arrangement tightness is reduced, which is conducive to the entry of water molecules. And THP and SA depend on CAHBs to form pharmaceutical salts, which changes THP from neutral to ionized, resulting in increased solubility of THP. This work implies that THP can improve its physicochemical properties by introducing special coformers to form pharmaceutical salts with supramolecular helical structure, which provides a theoretical basis for the subsequent improvement of the physicochemical properties of the protoberberine type compounds. Graphical abstract Download : Download high-res image (329KB) Download : Download full-size image

Co-Amorphous Telmisartan-Pimelic Acid with Improved Solubility

Improved in vitro and in vivo properties of telmisartan in the co-amorphous system with hydrochlorothiazide: A potential drug-drug interaction mechanism prediction

Structural Characterization and Pharmaceutical Evaluation of Telmisartan Hydrochloride Salts

Multicomponent Amorphous Solid Forms of Telmisartan: Insights into Mechanochemical Activation and Physicochemical Attributes

Nanoparticle of Telmisartan and Polyvinylpyrrolidone K-30: Characterization and Dissolution Study

Amino Acids As Co-Amorphous Excipients for Tackling the Poor Aqueous Solubility of Valsartan.

Investigation of the dissolution rate and oral bioavailability of atenolol-irbesartan co-amorphous systems

Azilsartan-nicotinamide cocrystal: Preparation, characterization and in vitro / vivo evaluation

A 3D in-vitro biomimicking Caco-2 intestinal permeability model-based assessment of physically modified telmisartan towards an alkalizer-free formulation development

Co-amorphous formulation of dipyridamole with p-hydroxybenzoic acid: Underlying molecular mechanisms, physical stability, dissolution behavior and pharmacokinetic study

Co-amorphous mixture of Erlotinib hydrochloride and Gallic acid for enhanced antitumor effects

Improving the solubility of tetrahydropalmatine by introducing sulfonic acid by forming pharmaceutical salts of tetrahydropalmatine with supramolecular helical structure via CAHBs

Enhanced Water Solubility and Oral Bioavailability of Paclitaxel Crystal Powders through an Innovative Antisolvent Precipitation Process: Antisolvent Crystallization Using Ionic Liquids as Solvent

Tranilast-matrine co-amorphous system: Strong intermolecular interactions, improved solubility, and physiochemical stability

ENHANCED SOLUBILITY AND DISSOLUTION BY SURFACE-MODIFIED SOLID DISPERSION OF ALECTINIB HYDROCHLORIDE

A novel drug-drug cocrystal of tegafur and myricetin: optimized properties of dissolution and tabletability

Candesartan Cilexetil Formulations in Mesoporous Silica: Preparation, Enhanced Dissolution In Vitro, and Oral Bioavailability In Vivo

Highly Efficient and Practical Synthesis of the Key Intermediate of Telmisartan

The preparation and physicochemical characterization of eprosartan mesylate-laden polymeric ternary solid dispersions for enhanced solubility and dissolution rate of the drug

How to Improve Solubility and Dissolution of Irbesartan by Fabricating Ternary Solid Dispersions: Optimization and In-Vitro Characterization

Improvement in Dissolution of Bosentan Monohydrate by Solid Dispersions Using Spray Drying Technique